21 CFR 341, Subpart C - Labeling
prev | next
- § 341.70 — Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).
- § 341.72 — Labeling of antihistamine drug products.
- § 341.74 — Labeling of antitussive drug products.
- § 341.76 — Labeling of bronchodilator drug products.
- § 341.78 — Labeling of expectorant drug products.
- § 341.80 — Labeling of nasal decongestant drug products.
- § 341.85 — Labeling of permitted combinations of active ingredients.
- § 341.90 — Professional labeling.
Title 21 published on 2012-04-01
no entries appear in the Federal Register after this date.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
